Association between increased mortality rate and antibiotic dose adjustment in intensive care unit patients with renal impairment.


Journal

European journal of clinical pharmacology
ISSN: 1432-1041
Titre abrégé: Eur J Clin Pharmacol
Pays: Germany
ID NLM: 1256165

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 30 07 2018
accepted: 24 09 2018
pubmed: 3 10 2018
medline: 4 4 2019
entrez: 3 10 2018
Statut: ppublish

Résumé

Adjusting the antibiotic dose based on an estimation of the glomerular filtration rate (eGFR) may result in subdosing, which may actually be significantly more problematic for intensive care unit (ICU) patients than not adjusting the dose. The aim of this study was to assess the outcomes of antibiotic dose adjustment in ICU patients with renal impairment. A retrospective cohort study was conducted in adult patients admitted to an ICU of a Brazilian hospital from January 2014 to December 2015. The eGFR was determined using Cockcroft-Gault and Modified Diet in Renal Disease equations for each day of hospitalization. Treatment failure was defined based on the clinical, laboratory, and radiological criteria. A total of 126 patients were assessed to meet the inclusion criteria and subsequently enrolled in the study (19.9% of patients admitted to the ICU during the study period). Of the 168 opportunities for dose adjustment, 99 (58.9%) adjustments were made. The mean eGFR in the group with dose adjustment was lower than that in the group without dose adjustment (38.5 vs. 40.7 mL/min/1.73 m In ICU patients with renal impairment, adjustments in antibiotic dose based on eGFR, significantly increased the risk of treatment failure and death.

Identifiants

pubmed: 30276417
doi: 10.1007/s00228-018-2565-7
pii: 10.1007/s00228-018-2565-7
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-126

Références

Nephron. 1976;16(1):31-41
pubmed: 1244564
Ann Intern Med. 2006 Aug 15;145(4):247-54
pubmed: 16908915
Crit Care Med. 2009 Mar;37(3):840-51; quiz 859
pubmed: 19237886
Int J Antimicrob Agents. 2009 Aug;34 Suppl 3:S14-9
pubmed: 19596109
Rev Bras Anestesiol. 2010 Jan-Feb;60(1):20-31
pubmed: 20169260
Intern Med J. 2011 Jul;41(7):537-43
pubmed: 21762334
Ann Pharmacother. 2013 Jul-Aug;47(7-8):1039-44
pubmed: 23757387
BMC Geriatr. 2013 Sep 10;13:92
pubmed: 24020893
PLoS One. 2014 Apr 22;9(4):e95991
pubmed: 24755778
Invest New Drugs. 2014 Oct;32(5):913-27
pubmed: 24788562
Drugs Aging. 2014 Jul;31(7):493-9
pubmed: 24902935
Intern Med J. 2014 Jun;44(6):591-6
pubmed: 24946814
J Intensive Care. 2014 May 07;2(1):31
pubmed: 25520843
Int J Environ Res Public Health. 2015 Sep 09;12(9):11227-40
pubmed: 26371029
Expert Opin Drug Saf. 2016 May;15(5):667-78
pubmed: 26961691
Expert Rev Clin Pharmacol. 2016 Jul;9(7):961-79
pubmed: 27018631
Crit Care. 2016 Apr 04;20:79
pubmed: 27039986
Clin Microbiol Infect. 2016 Jul;22(7):625-31
pubmed: 27145210
Clin Pharmacokinet. 2017 Feb;56(2):193-205
pubmed: 27417226
Eur J Clin Pharmacol. 2016 Dec;72(12):1433-1439
pubmed: 27568310
BMC Nephrol. 2017 Jan 17;18(1):26
pubmed: 28095816
Clin Infect Dis. 2017 Aug 15;65(4):644-652
pubmed: 28472416
An Sist Sanit Navar. 2017 Apr 30;40(1):119-130
pubmed: 28534544
J Clin Diagn Res. 2017 May;11(5):BC09-BC12
pubmed: 28658750
J Microbiol Immunol Infect. 2018 Dec;51(6):763-769
pubmed: 28716359
Ther Drug Monit. 2017 Dec;39(6):604-613
pubmed: 29084032
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568
pubmed: 29216348

Auteurs

Marianne Silveira Camargo (MS)

Post-Graduate Program in Medicine and Health, Federal University of Bahia, Rua Padre Feijó, S/N, Canela, Salvador, Bahia, Brazil. marianne_camargo@hotmail.com.
, Rua Rio de Contas, n. 350, Candeias, Vitória da Conquista, 45029-094, Bahia, Brazil. marianne_camargo@hotmail.com.

Sóstenes Mistro (S)

Post-Graduate Program in Public Health, Multidisciplinary Institute of Health, Federal University of Bahia, Rua Rio de Contas, 58, Vitória da Conquista, Bahia, Brazil.

Márcio Galvão Oliveira (MG)

Post-Graduate Program in Public Health, Multidisciplinary Institute of Health, Federal University of Bahia, Rua Rio de Contas, 58, Vitória da Conquista, Bahia, Brazil.

Luiz Carlos Santana Passos (LCS)

Post-Graduate Program in Medicine and Health, Federal University of Bahia, Rua Padre Feijó, S/N, Canela, Salvador, Bahia, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH